Hoyland,
Thank you for taking the time to answer my query. I accept what you are saying makes a lot of sense and certainly hope you are correct.
I guess what's thrown me is that after this ASX announcement (21/7/14) there has not been, to my knowledge, any other reference to transduction - I suppose we just assume it happened but it would be nice to have that confirmed
"The! first! patient! dosed! in the! trial! has to! date! experienced! no!treatmentJrelated! adverse!effects.!Liver!biopsy!results!from!the!first!patient!were encouraging!and!in! line! with! expectations.! ! TTJ034! DNA! and! short! hairpin! RNA! (shRNA)! were! both! detected! in! the! biopsy!at! subJtherapeutic! levels,! indicating! that! liver! transduction! occurred.!"
Cheers amc
- Forums
- ASX - By Stock
- BLT
- Benitec doesn’t have an IPO story
Benitec doesn’t have an IPO story, page-12
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online